---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024726"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:42:29.690351+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sonim shareholders approve reverse stock split, authorized share increase, and equity plan expansion

## Summary
- Approved reverse stock split at ratio of 1-for-2 to 1-for-15, at Board discretion, within one year.
- Approved increase in authorized common stock from 100M to 200M shares, at Board discretion within one year.
- Approved amendment to 2019 Equity Incentive Plan adding 3,000,000 shares for issuance.
- Stockholders did NOT approve proposal to limit officer liability under Delaware law.
- Re-elected five directors and ratified Moss Adams as independent auditor for FY2024.

## SEC filing metadata
- accession: 0001493152-24-024726
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315224024726/0001493152-24-024726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315224024726/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024726
- JSON: https://secwatch.observer/filing/0001493152-24-024726.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.